Advertisement

Biotech firms target artificial blood

ARLINGTON, Va., Feb. 7 (UPI) -- Biotechnology firms are continuing their efforts to win Food and Drug Administration approval for artificial blood. Jerry Squires, a scientist at the American Red Cross Biomedical Services, said such a breakthrough could ease blood shortages and save lives.

Advertisement

Latest Headlines